New York City: Start Spreading the News

Growing up in the suburbs of New York in the 1970s, as one of us (IO) did, was not necessarily a good time to fall in love with the city.

Written byIvan Oransky
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Growing up in the suburbs of New York in the 1970s, as one of us (IO) did, was not necessarily a good time to fall in love with the city. It was a time of historic blackouts, the Son of Sam, and the infamous Daily News headline FORD TO CITY: DROP DEAD. But it was also a decade during which the Yankees went back to the World Series, and the city began rebounding. In many ways, it hasn't looked back.

The life sciences industry's relationship with New York is more complicated, even the reverse. Things tend to start well. The city's 25 biomedical institutions and 147 hospitals get more than $1 billion in funding from the NIH annually, and the area's institutions have been granted more biotechnology patents than any other region. Some of the graduates and faculty of those institutions create an average of 30 biotech startups per year.

...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies